Literature DB >> 27317650

NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.

Nobuhisa Takase1, Yu-Ichiro Koma2, Naoki Urakawa1, Mari Nishio2, Noriaki Arai2, Hiroaki Akiyama2, Manabu Shigeoka2, Yoshihiro Kakeji3, Hiroshi Yokozaki4.   

Abstract

Tumor-associated macrophages (TAMs) have important roles in the angiogenesis and tumor immunosuppression of various cancers, including esophageal squamous cell carcinomas (ESCCs). To elucidate the roles of TAMs in ESCCs, we compared the gene expression profiles between human peripheral blood monocyte-derived macrophage-like cells (Macrophage_Ls) and Macrophage_Ls stimulated with conditioned medium of the TE series human ESCC cell line (TECM) (TAM_Ls) using cDNA microarray analysis. Among the highly expressed genes in TAM_Ls, we focused on neural cell adhesion molecule (NCAM). NCAM knockdown in TAM_Ls revealed a significant decrease of migration and survival via a suppression of PI3K-Akt and fibroblast growth factor receptor 1 (FGFR1) signaling. Stimulation by TECM up-regulated the level of FGFR1 in Macrophage_Ls. Recombinant human fibroblast growth factor-2 (rhFGF-2) promoted the migration and survival of TAM_Ls and TE-cells through FGFR1 signaling. Our immunohistochemical analysis of 70 surgically resected ESCC samples revealed that the up-regulated FGF-2 in stromal cells, including macrophages, was associated with more aggressive phenotypes and a high number of infiltrating M2 macrophages. These findings may indicate a novel role of NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of ESCCs.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; FGF-2; FGFR1; Macrophage; NCAM; Tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27317650     DOI: 10.1016/j.canlet.2016.06.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

Authors:  Elizabeth Ann L Enninga; Kyriakos Chatzopoulos; John T Butterfield; Shari L Sutor; Alexey A Leontovich; Wendy K Nevala; Thomas J Flotte; Svetomir N Markovic
Journal:  J Pathol       Date:  2018-06-28       Impact factor: 7.996

2.  HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.

Authors:  Fengjuan Cheng; Guanhua Qian; Xianyun Fang; Jingjie Sun; Siyuan Chen; Rongjuan Chen; Shangjing Liu; Zhaodi Li; Kejia Wu; Shiming Jiang; Yong Chen; Ni Tang; Juan Chen; Changzhu Duan
Journal:  Hepatol Int       Date:  2021-04-19       Impact factor: 6.047

3.  Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.

Authors:  Osamu Maehara; Goki Suda; Mitsuteru Natsuizaka; Shunsuke Ohnishi; Yoshito Komatsu; Fumiyuki Sato; Masato Nakai; Takuya Sho; Kenichi Morikawa; Koji Ogawa; Tomoe Shimazaki; Megumi Kimura; Ayaka Asano; Yoshiyuki Fujimoto; Shinya Ohashi; Shingo Kagawa; Hideaki Kinugasa; Seiji Naganuma; Kelly A Whelan; Hiroshi Nakagawa; Koji Nakagawa; Hiroshi Takeda; Naoya Sakamoto
Journal:  Carcinogenesis       Date:  2017-10-26       Impact factor: 4.944

Review 4.  Ubiquitous Neural Cell Adhesion Molecule (NCAM): Potential Mechanism and Valorisation in Cancer Pathophysiology, Drug Targeting and Molecular Transductions.

Authors:  S Sowparani; P Mahalakshmi; J Pushpa Sweety; Arul Prakash Francis; U M Dhanalekshmi; N Selvasudha
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

Review 5.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.

Authors:  De-Chen Lin; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 33.883

6.  CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells.

Authors:  Masayoshi Hosono; Yu-Ichiro Koma; Nobuhisa Takase; Naoki Urakawa; Nobuhide Higashino; Kazuki Suemune; Himiko Kodaira; Mari Nishio; Manabu Shigeoka; Yoshihiro Kakeji; Hiroshi Yokozaki
Journal:  Oncotarget       Date:  2017-11-20

7.  E3 ligase UHRF2 stabilizes the acetyltransferase TIP60 and regulates H3K9ac and H3K14ac via RING finger domain.

Authors:  Shengyuan Zeng; Yangyang Wang; Ting Zhang; Lu Bai; Yalan Wang; Changzhu Duan
Journal:  Protein Cell       Date:  2016-10-14       Impact factor: 14.870

8.  Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy.

Authors:  Sumanta K Pal; Dayson Moreira; Haejung Won; Seok Woon White; Pryanka Duttagupta; Marc Lucia; Jeremy Jones; JoAnn Hsu; Marcin Kortylewski
Journal:  Int J Mol Sci       Date:  2019-04-13       Impact factor: 5.923

9.  Application of CNTF or FGF-2 increases the number of M2-like macrophages after optic nerve injury in adult Rana pipiens.

Authors:  Rosa E Blanco; Giam S Vega-Meléndez; Valeria De La Rosa-Reyes; Clarissa Del Cueto; Jonathan M Blagburn
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

10.  FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma.

Authors:  Osamu Maehara; Goki Suda; Mitsuteru Natsuizaka; Taku Shigesawa; Gouki Kanbe; Megumi Kimura; Masaya Sugiyama; Masashi Mizokami; Masato Nakai; Takuya Sho; Kenichi Morikawa; Koji Ogawa; Shinya Ohashi; Shingo Kagawa; Hideaki Kinugasa; Seiji Naganuma; Naoto Okubo; Shunsuke Ohnishi; Hiroshi Takeda; Naoya Sakamoto
Journal:  Cancer Biol Ther       Date:  2021-07-05       Impact factor: 4.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.